{
    "2019-05-20": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study",
                "features": {
                    "keywords": [
                        "Adverum",
                        "FDA",
                        "Lifts Hold",
                        "Wet AMD Study"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Ways to Buy Into the Marijuana Boom Without the Risk",
                "features": {
                    "keywords": [
                        "Marijuana",
                        "Boom",
                        "Investment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "cannabis",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Ligand Grants Preclinical Candidate Rights to UK-based Firm",
                "features": {
                    "keywords": [
                        "Ligand",
                        "Preclinical",
                        "Candidate Rights",
                        "UK-based Firm"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}